Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care

Core Viewpoint - Rocket Doctor AI Inc. has successfully completed the acquisition of Alea Health Holdings Ltd., enhancing its digital health platform and supporting its mission to improve access to high-quality healthcare, particularly for underserved communities across North America [1][6]. Transaction Overview - The acquisition involved Rocket Doctor AI acquiring 100% of Alea's ordinary shares through a cash payment of US $15,000 and the issuance of 285,712 common shares valued at CAD $0.70 each [4]. - The company will also assume Alea's obligations under a Simple Agreement for Future Equity (SAFE Note), with a principal balance of US $180,000 to be paid in monthly installments of US $22,500 [5]. Strategic Importance - The acquisition is seen as a significant step in Rocket Doctor AI's strategy to build a scalable, physician-led digital health ecosystem, integrating Alea's technology to enhance clinical workflows and decision support [2][3]. - Alea's technology will be incorporated into Rocket Doctor AI's platform, aiming to improve care consistency and expand access to healthcare for patients, especially in remote areas [3][10]. Company Background - Rocket Doctor AI delivers AI-powered healthcare solutions designed to enhance the patient journey, with a focus on evidence-based care and improving patient outcomes [8][10]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, emphasizing efficiency and autonomy for physicians [9].